Chihiro Yabe
Corporate Officer/Principal bei Kyoto Prefectural University of Medicine
Aktive Positionen von Chihiro Yabe
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Kyoto Prefectural University of Medicine | Corporate Officer/Principal | - | - |
Karriereverlauf von Chihiro Yabe
Ehemalige bekannte Positionen von Chihiro Yabe
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Calliditas Therapeutics Suisse SA
 Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Calliditas Therapeutics Suisse SA engages in the development of NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes, which amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company was founded Chihiro Yabe, Robert A. Clark, David Lambeth, and Karl-Heinz Krause in 2006 and is headquartered in Geneva, Switzerland. | Gründer | 01.01.2006 | - |
Statistik
International
| Schweiz | 2 |
| 2 |
Operativ
| Founder | 1 |
| Corporate Officer/Principal | 1 |
Sektoral
| Health Technology | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Calliditas Therapeutics Suisse SA
Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Calliditas Therapeutics Suisse SA engages in the development of NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes, which amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company was founded Chihiro Yabe, Robert A. Clark, David Lambeth, and Karl-Heinz Krause in 2006 and is headquartered in Geneva, Switzerland. | Health Technology |
- Börse
- Insiders
- Chihiro Yabe
- Erfahrung
